C57BL/6NTac-Arhgef4tm1a(KOMP)Wtsi/Wtsi

Status

Available to order

EMMA IDEM:12046
International strain nameC57BL/6NTac-Arhgef4tm1a(KOMP)Wtsi/Wtsi
Alternative nameEPD0135_1_A05
Strain typeTargeted Mutant Strains
Allele/Transgene symbolArhgef4tm1a(KOMP)Wtsi
Gene/Transgene symbolArhgef4
DisclaimerPlease note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
  1. We can not guarantee a null mutation for Knock-out first alleles (tm1a alleles, see http://www.mousephenotype.org/about-ikmc/targeting-strategies) as the critical exon has not been deleted.
  2. That the structure of the targeted mutation in the ES cells obtained from EUCOMM/KOMP to generate EUCOMM/KOMP mice is not verified by INFRAFRONTIER/EMMA. It is recommended that the recipient confirms the mutation structure.
  3. No check for determining the copy number of the targeting construct in ES cells obtained from EUCOMM/KOMP is done by INFRAFRONTIER/EMMA.
  4. The level of quality control before mice are released is to confirm the individual mouse genotype by short range PCR.

Information from provider

Provider Wellcome Trust Sanger Institute
Provider affiliationWellcome Trust Sanger Institute
Genetic informationThis mouse line originates from KOMP ES clone EPD0135_1_A05. For further details on the construction of this clone see the page at the IMPC portal.
Phenotypic informationPotential phenotyping data in the IMPC portal
References
  • Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes.;White Jacqueline K, Gerdin Anna-Karin, Karp Natasha A, Ryder Ed, Buljan Marija, Bussell James N, Salisbury Jennifer, Clare Simon, Ingham Neil J, Podrini Christine, Houghton Richard, Estabel Jeanne, Bottomley Joanna R, Melvin David G, Sunter David, Adams Niels C, null null, Tannahill David, Logan Darren W, Macarthur Daniel G, Flint Jonathan, Mahajan Vinit B, Tsang Stephen H, Smyth Ian, Watt Fiona M, Skarnes William C, Dougan Gordon, Adams David J, Ramirez-Solis Ramiro, Bradley Allan, Steel Karen P, ;2013;Cell;154;452-64; 23870131

Information from EMMA

Archiving centreWellcome Trust Sanger Institute, Hinxton, United Kingdom
Animals used for archivinghomozygous C57BL/6N, wild-type C57BL/6N
Stage of embryos2-cell

Disease and phenotype information

IMPC phenotypes (allele matching)
  • increased bone mineral density / IMPC
  • decreased bone mineral density / IMPC
  • decreased circulating HDL cholesterol level / IMPC
  • increased circulating calcium level / IMPC
  • decreased body weight / IMPC
  • abnormal lens morphology / IMPC
  • cataract / IMPC
  • increased circulating free fatty acids level / IMPC
  • abnormal vibrissa morphology / IMPC
  • decreased circulating triglyceride level / IMPC
  • decreased circulating free fatty acids level / IMPC
  • decreased hemoglobin content / IMPC
  • increased lactate dehydrogenase level / IMPC
  • increased circulating alkaline phosphatase level / IMPC
  • increased lean body mass / IMPC
  • abnormal behavior / IMPC
  • decreased T cell number / IMPC
  • decreased circulating cholesterol level / IMPC
  • abnormal response to tactile stimuli / IMPC
  • increased circulating aspartate transaminase level / IMPC
  • decreased circulating serum albumin level / IMPC
  • decreased blood urea nitrogen level / IMPC
  • increased circulating total protein level / IMPC
  • increased mature B cell number / IMPC
  • decreased total body fat amount / IMPC
IMPC phenotypes (gene matching)
  • decreased circulating serum albumin level / IMPC
  • cataract / IMPC
  • decreased bone mineral density / IMPC
  • increased lean body mass / IMPC
  • increased lactate dehydrogenase level / IMPC
  • increased circulating total protein level / IMPC
  • abnormal lens morphology / IMPC
  • decreased T cell number / IMPC
  • increased circulating free fatty acids level / IMPC
  • decreased blood urea nitrogen level / IMPC
  • decreased hemoglobin content / IMPC
  • decreased circulating HDL cholesterol level / IMPC
  • increased circulating calcium level / IMPC
  • decreased circulating free fatty acids level / IMPC
  • decreased circulating cholesterol level / IMPC
  • abnormal vibrissa morphology / IMPC
  • abnormal response to tactile stimuli / IMPC
  • abnormal behavior / IMPC
  • increased mature B cell number / IMPC
  • decreased total body fat amount / IMPC
  • increased circulating alkaline phosphatase level / IMPC
  • increased circulating aspartate transaminase level / IMPC
  • decreased body weight / IMPC
  • decreased circulating triglyceride level / IMPC
  • increased bone mineral density / IMPC
MGI phenotypes (gene matching)
  • no abnormal phenotype detected / MGI
  • decreased tumor growth/size / MGI
  • abnormal tumor morphology / MGI
  • abnormal vascular endothelial cell migration / MGI
  • abnormal vascular endothelial cell physiology / MGI
  • decreased angiogenesis / MGI
  • abnormal tumor vascularization / MGI

Literature references

  • Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes.;White Jacqueline K, Gerdin Anna-Karin, Karp Natasha A, Ryder Ed, Buljan Marija, Bussell James N, Salisbury Jennifer, Clare Simon, Ingham Neil J, Podrini Christine, Houghton Richard, Estabel Jeanne, Bottomley Joanna R, Melvin David G, Sunter David, Adams Niels C, null null, Tannahill David, Logan Darren W, Macarthur Daniel G, Flint Jonathan, Mahajan Vinit B, Tsang Stephen H, Smyth Ian, Watt Fiona M, Skarnes William C, Dougan Gordon, Adams David J, Ramirez-Solis Ramiro, Bradley Allan, Steel Karen P, ;2013;Cell;154;452-64; 23870131

Information on how we integrate external resources can be found here

Register interest

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).